ArticleCurrent issues in molecular biology2025

Dihydromyricetin Remodels the Tumor Immune Microenvironment in Hepatocellular Carcinoma: Development and Validation of a Prognostic Model.

Yang Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.